Fundraising Fox
Spectrum Pharmaceuticals
Henderson, US · Founded 2002 · Delaware corporation · 144 employees on LinkedIn
Find your way into Spectrum Pharmaceuticals
Each arrow is one introduction. Sign up to fill in the first one.
195 people can intro you to Kurt
Ask Raymond Cohen to introduce you to Kurt Gustafson
You →Raymond · together at Spectrum Pharmaceuticals →Kurt
113 people can intro you to Joseph
Ask Jamie Chen to introduce you to Joseph Turgeon
You →Jamie · together at Spectrum Pharmaceuticals →Joseph
Sign up to find every way you can get introduced to Spectrum Pharmaceuticals
- Your email: who you already know at Spectrum Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Spectrum Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
RC
Rajesh C. ShrotriyaExecutive
KA
Kurt A. GustafsonChief Financial Officer2013–2022Kurt Gustafson spent 15 years at Amgen in progressively senior financial roles, including Treasurer and CFO of International Operations, before joining Halozyme Therapeutics as CFO in 2009. He subsequently held the CFO position at Spectrum Pharmaceuticals starting in 2013 and later at OmniAb, and holds degrees in Accounting from North Park University and an MBA from UCLA.
JT
Joseph TurgeonSenior Compliance Manager2019–2022Joseph Turgeon has spent over 10 years in specialty pharmaceutical sales and market access roles focused on oncology, working with healthcare providers to support patient access to therapies in the buy-and-bill market. He has held positions spanning clinical operations, reimbursement strategy, and account management across community and academic settings.
Board
AE
Anthony E. MaidaBoard director
GR
Gilles R. GagnonBoard director
SM
Stuart M. KrasnerBoard director
LL
Luigi LenazBoard director
RW
DV
Dolatrai VyasBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2016
▶$3MraisedApr 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$3MraisedApr 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anthony E. MaidaDirector
- Gilles R. GagnonDirector
- Stuart M. KrasnerDirector
- Luigi LenazDirector
- Rajesh C. ShrotriyaExecutive Officer, Director
- Raymond W. CohenDirector
- Kurt A. GustafsonExecutive Officer
- Joseph TurgeonExecutive Officer
- Dolatrai VyasDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Spectrum Pharmaceuticals raised?
- Spectrum Pharmaceuticals has disclosed $3M raised across 1 round.
- Where is Spectrum Pharmaceuticals headquartered?
- Spectrum Pharmaceuticals is headquartered in Henderson, US.